AstraZeneca Pharma India Limited

NSE ASTRAZEN.NS

AstraZeneca Pharma India Limited Operating Cash Flow for the year ending March 31, 2024: USD 3.34 M

AstraZeneca Pharma India Limited Operating Cash Flow is USD 3.34 M for the year ending March 31, 2024, a -52.89% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

AstraZeneca Pharma India Limited Operating Cash Flow for the year ending March 31, 2023 was USD 7.09 M, a -46.57% change year over year.
AstraZeneca Pharma India Limited Operating Cash Flow for the year ending March 31, 2022 was USD 13.28 M, a -7.23% change year over year.
AstraZeneca Pharma India Limited Operating Cash Flow for the year ending March 31, 2021 was USD 14.31 M, a 23.35% change year over year.
AstraZeneca Pharma India Limited Operating Cash Flow for the year ending March 31, 2020 was USD 11.60 M, a 46.63% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

NSE: ASTRAZEN.NS

AstraZeneca Pharma India Limited

CEO	Dr. Sanjeev Kumar Panchal
IPO Date	July 1, 2002
Location	India
Headquarters	Manyata Embassy Business Park
Employees	940
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Key trends

Past 5 years